Overview

Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection

Status:
Completed
Trial end date:
2019-08-31
Target enrollment:
0
Participant gender:
All
Summary
Randomized open label clinical trial to compare the clinical and microbiological efficacy of fecal microbiota transplantation, fidaxomicin, and vancomycin for relapsing Clostridium difficile infection
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Aarhus
Treatments:
Fidaxomicin
Vancomycin
Criteria
Inclusion Criteria:

1. Relapse of Clostridium difficile infection with previous trial of vancomycin or
fidaxomicin

Exclusion Criteria:

1. Pregnancy or breastfeeding

2. Does not speak or understand the Danish language

3. Current antibiotic treatment other than metronidazole, vancomycin, fidaxomicin

4. fulminant colitis which contraindicates medical treatment

5. physician's evaluation that the patient cannot tolerate project inclusion